Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus placebo crossover study on sleep duration variation and glucose variability in type 2 diabetes
RBR-6wg54rbPhase 3Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of melatonin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Universidade Federal de Minas Gerais. Primary endpoint: Change in glucose variability. Started Sep 2022; status: completed.
02
Drugs
melatonin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on RBR-6wg54rb.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6wg54rb.